Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • fantomen99 fantomen99 Sep 6, 2011 9:01 AM Flag

    Primary listing to Stockholm Exchange

    EpiCept: Moves the share of primary listing to Stockholm

    (SIX)
    Biotechnology Company Epicept move its primary listing of shares to
    the Stockholm Stock Exchange, effective today, September 5.

    The share was previously a secondary listing on the Stockholm Stock Exchange.

    It appears from a stock exchange release.

    EpiCept is also listed on Nasdaq. The Company do however currently not comply with the Nasdaq requirements for a minimum share price of $ 1.

    Henry Öhlin, +46 31 350 64 87
    henrik.ohlin @ six-group.se
    SIX News
    ---------------------------

    strange, this information is hard to find in the U.S

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IMNP
1.66-0.05(-2.92%)Jul 31 3:59 PMEDT